Identifying the ‘Achilles heel’ of type 1 diabetes

Author:

Battaglia M12,Buckner J H3,Levings M K4ORCID,Richardson S J5,Wong F S6ORCID,Tree T I78

Affiliation:

1. San Raffaele Diabetes Research Institute, IRCCS San Raffaele Hospital, Milan, Italy

2. Telethon Foundation, Milan, Italy

3. Translational Research Program, Benaroya Research Institute at Virginia Mason, Seattle, WA, USA

4. BC Children's Hospital Research Institute, Vancouver, BC, Canada

5. Institute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter, UK

6. Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, UK

7. Department of Immunobiology, School of Immunology and Microbial Sciences (SIMS), King's College London, London, UK

8. NIHR Biomedical Research Centre, Guy's and St Thomas’ NHS Foundation Trust and King's College London, London, UK

Abstract

Summary When Thetis dipped her son Achilles into the River Styx to make him immortal, she held him by the heel, which was not submerged, and thus created a weak spot that proved deadly for Achilles. Millennia later, Achilles heel is part of today's lexicon meaning an area of weakness or a vulnerable spot that causes failure. Also implied is that an Achilles heel is often missed, forgotten or under-appreciated until it is under attack, and then failure is fatal. Paris killed Achilles with an arrow ‘guided by the Gods’. Understanding the pathogenesis of type 1 diabetes (T1D) in order to direct therapy for prevention and treatment is a major goal of research into T1D. At the International Congress of the Immunology of Diabetes Society, 2018, five leading experts were asked to present the case for a particular cell/element that could represent ‘the Achilles heel of T1D’. These included neutrophils, B cells, CD8+ T cells, regulatory CD4+ T cells, and enteroviruses, all of which have been proposed to play an important role in the pathogenesis of type 1 diabetes. Did a single entity emerge as ‘the’ Achilles heel of T1D? The arguments are summarized here, to make this case.

Publisher

Oxford University Press (OUP)

Subject

Immunology,Immunology and Allergy

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Personalized Immunotherapies for Type 1 Diabetes: Who, What, When, and How?;Journal of Personalized Medicine;2022-03-29

2. Clinical & Experimental Immunology: Highlights of 2021;Clinical and Experimental Immunology;2021-12-04

3. Historical and new insights into pathogenesis of type 1 diabetes (2);Clinical and Experimental Immunology;2021-04-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3